GILD Gilead Sciences Inc

Gilead Sciences, Inc. (GILD) is currently at $66.74, up $3.54 or 5.6%

-- Would be highest close since Dec. 23, 2019, when it closed at $66.75

-- On pace for largest percent increase since Aug. 30, 2017, when it rose 7.25%

-- On Friday, The Wall Street Journal reported that Chinese officials had reached an agreement with Gilead to test remdesivir in patients with coronavirus. The same day, the New England Journal of Medicine published a case report on a man sickened with the coronavirus in Washington state who was given remdesivir, and whose condition began to improve the following day

-- Snaps a three day losing streak

-- Down 45.39% from its all-time closing high of $122.21 on June 23, 2015

-- Traded as high as $68.68; highest intraday level since July 5, 2019, when it hit $69.34

-- Up 8.67% at today's intraday high; largest intraday percent increase since Nov. 12, 2012, when it rose as much as 14.35%

-- Best performer in the S&P 500 today

-- Third best performer in the Nasdaq 100 today

All data as of 2:58:18 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

February 03, 2020 15:21 ET (20:21 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.